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Oral endotoxin in healthy adults
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This article presents a study that measured oral endotoxin levels in healthy persons with the Limuius 
amoebocyte lysate microassay. Only young nonsmoking adults with a healthy dentition measured with the plaque index 
and a good level of oral hygiene based on a twice-daily (morning and evening) tooth-brushing regimen were admitted to 
this open study. Each person was required to provide two ora! washings of 10 ml sterile saline solution 1 week apart. 
Only those volunteers without oral carriage of aerobic gram-negative bacilli were enrolled in the baseline study. A total 
of 15 healthy adults with a median age of 29 years (range, 25 to 43 years) were included in the trial. The mean plaque 
score of the group was 1.2 ±  0,1. They ail maintained a twice-daily tooth-brushing regimen unaltered throughout the 
sampling period. A total of 30 mouth rinses were studied. None of the samples yielded potential pathogens including 
aerobic gram-negative bacilli. Staphylococcus aureus and yeasts; a culturing technique based on preenrichment in 
nutrient medium was used. Data showed mean oral endotoxin levels of 20 ng per ml of mouth rinse; the aerobic E. co/i 
endotoxin was used as the classical standard. This is equivalent to 1 mg of anaerobic endotoxin per ml of undiluted 
saliva after correcting for the 10 to 102 dilution factor of the mouth rinse itself and for the 103 times less sensitivity of 
anaerobic endotoxin in the Limuius amoebocyte lysate-assay. The discussion includes the physiologic and clinical 
benefit of the low endotoxicity of anaerobic gram-negative flora apart from the technical aspects of both culture and 
endotoxin assays used in the study. (Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:637-43)
Severity of underlying disease is thought to determine 
the oropharyngeal carnage of “ normal” versus “ ab­
normal'’ potential pathogens.1 Both chronic and
The microbiologic observation that surveillance 
samples of the oropharynx of healthy persons in gen-
acute underlying conditions promote the acquisition 
and subsequent oral carriage of * ‘abnormal’ ’ aerobic 
gram-negative bacilli (AGNB).2,3 Apart from the in­
digenous anaerobic (e.g., Bacteroides sp) and aerobic 
(e.g., viridans streptococci) mouth flora, healthy 
people may carry “ normal” potential pathogens such 
as Streptococcus pneumoniae and Staphylococcus 
aureus . 4  Oral carnage of AGNB is uncommon in 
healthy persons.5 A glycoprotein fibronectin that 
covers the oropharyngeal mucosae has been shown to 
possess attachment sites for gram-positive microor­
ganisms including S. pneumoniae and S. aureus,6 
whereas receptor sites for AGNB are thought to 
emerge after denudement of the oral mucosae from 
fibronectin caused by underlying disease.7
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eral do not contain AGNB has been clinically used to 
distinguish subsets of patients at high risk of infection 
from patients at low risk.8,9 In the same population 
of immunocompromised patients, AGNB carriage 
has been associated with an endotoxin pool thought 
to contribute to the systemic inflammatory response 
syndrome (SIRS) after absorption through the ali­
mentary mucosal lining.10 Most work has been done 
on the intestinal endotoxin pool with fecal sam­
ples.11,12 However, microbiologically and immuno- 
logically the oropharynx is an integral part of the di­
gestive tract. For example, persons who do not carry 
AGNB in the oropharynx, only harbor the indigenous 
Escherichia coli in the gut.13 Patients who carry 
Pseudomonas aeruginosa in the mouth are generally 
fecal carriers of the same strain.3 Much of the diffi­
culty in developing protocols for oral immunization 
has involved the delivery of sufficient antigen to ef­
fectively immunize the host without development of
oral tolerance.14
Before embarking on studying different homoge­
neous patient populations, we believe that the estab­
lishment of baseline values of oral endotoxin in a 
healthy group is mandatory. A MEDLINE search of 
the literature from 1985 to 1995 that used the terms 
oral endotoxin failed to reveal any studies that 
addressed the levels of oral endotoxin in healthy per­
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sons. This prompted us to apply the existing Limuius 
gelation microassay for the detection of endotoxin in 
oral washings of 15 healthy persons without oral 
AGNB carriage.
VOLUNTEERS AND METHODS 
Subjects
The inclusion criteria were as follows: (1) older 
than 18 years and nonsmoking; (2) in good general 
health; (3) no antibiotic intake for at least 3 months 
before the study; (4) healthy dentition evaluated by 
the plaque index; (5) a good level of oral hygiene; and 
(6) free of AGNB in the oropharynx.
Health status of the subjects
Subjects with a chronic underlying disease such 
as diabetes, alcoholism, chronic obstructive pulmo­
nary disease, or liver, kidney, or heart disease were 
excluded. All these conditions promote oropharyn­
geal AGNB carriage.2 Young adults with viral 
illnesses of the respiratory tract that are always asso­
ciated with oral mucositis were not allowed to partic­
ipate because of increased adherence of AGNB to in­
fected mucosal cells.15
Oral health status
Neither carious lesions nor prosthetic appliances 
were allowed. All volunteers were examined by the 
same clinical-dental hygienist team led by one of us 
(L.T.S.). AH 15 persons received an oral examination 
that included an assessment of the amount of dental 
plaque present on six teeth: the upper right first mo­
lar, upper right central incisor, upper left first premo­
lar, lower left first molar, lower left central incisor, 
and lower right first premolar. The buccal and lingual 
surfaces at the gingival margin of the teeth were 
scored according to a simplified modification of the 
semiquantitative plaque index first described by 
Silness and Loe.16 The amount of plaque seen on 
the tooth was given a score of 0 to 3 (0 = no plaque 
noted; 1 = plaque seen only on the tip of an explorer 
passed over the tooth surface; 2 = plaque obvious 
with the naked eye; 3 = gross deposits of plaque 
present over the entire tooth). For those persons 
missing any of the index teeth, the teeth remaining 
closest to those missing index teeth were scored. A 
single score was given for each tooth that represented 
the surface harboring the most plaque. This oral ex­
amination was performed only once, at the time of the 
first gargling.
Oral hygiene
Only nonsmoking subjects with a good level of oral 
hygiene, (i.e., who brushed their teeth minimally two 
times daily) were enrolled in the open study. The
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subjects were instructed to maintain a twice-daily 
(morning and evening) tooth-brushing regimen unal­
tered throughout the sampling period and to avoid any 
kind of mouth rinses, lozenges, or antimicrobial 
agents. The possible variations as a result of eating 
and drinking were minimized by sampling at 11 a m  
approximately 3 hours after breakfast.
Oral washings
The volunteers rinsed and gargled with 10 ml of 
sterile pyrogen-free saline (SPFS) solution for 30 
seconds. The oral washings were collected in sterile 
vials (Cordis Laboratories, Roden, The Netherlands). 
One week later the second sample was collected in the 
same way.
Microbiologic techniques
Samples were transported to the laboratory and 
processed by an experienced senior technician within
1 hour of collection.17 One milliliter of sample was 
added to 9 ml of brain heart infusion (BHI) broth (Lab 
M, Salford, England), to make serial tenfold dilutions. 
Dilution series were made in trays of 64 (8 x 8) cups 
of 1.5 ml (Thovadec, Ede, The Netherlands). Each 
cup was filled with 0.45 ml of BHI. A 0.05 ml sam­
ple from the 1:10 diluted mouth rinse was mixed with 
0.45 ml BHI in the first cup, resulting in a 1:100 oral 
washing. All dilution steps from 10~2 through 10-9 
were prepared in BHI with 0.05 ml microdiluters 
(Dynatech AG, Zug, Switzerland). The samples were 
incubated at 37°C for 18 hours. The number of cups 
that showed turbidity from the growth of microor­
ganisms indicated the logarithm of the concentration 
of microorganisms per millimeter of mouth rinse 
(quantitative determination). Thereafter, all the dilu­
tions with growth were inoculated on MacConkey 
agar (BBL, Heidelberg, Germany), yeast morphology 
agar (Merck, Darmstadt, Germany), and blood agar 
(BBL) for qualitative determination. AGNB were 
evaluated on MacConkey agar, yeasts on yeast mor­
phology agar, and streptococci and staphylococci on 
blood agar. Morphologically distinct colonies were 
isolated in pure culture. The identification of AGNB 
was performed by means of the biochemical test of 
API 20E (API B.V.’s, Hertogenbosch, The Nether­
lands). Staphylococcus aureus was distinguished 
from coagulase-negative staphylococci by means of 
the slide agglutination test to detect clumping factor 
and protein A. If the results were inconclusive, a 
tube-coagulase test was done. All results were ex­
pressed by logio of colony-forming units per ml of 
mouth rinse.
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Determination of the endotoxin concentration in 
oral washings
The endotoxin concentration in the oral washings 
was determined by a microtechnique of the Limuius 
amebocyte lysate (LAL) test.18 The equipment and 
materials used included pyrogen-free glass test tubes, 
slides, micropipettes (1, 2, 3, 4, and 5|il), hand 
pipettes with sterile tips (Finnpipette, Helsinki, Fin­
land), an incubator at 37°C ± 1°C, and a colored so­
lution containing 0.1% bromophenol blue (Merck, 
Darmstadt, Germany) in 96% ethanol diluted to 20% 
with phosphate-buffered saline solution without Ca2+. 
Sterile pyrogen-free saline (SPFS) solution was used 
to dissolve all reagents and used as a negative control. 
It was also used for the preparation of standards and 
predilution of the samples. All materials coming in 
contact with specimen or test material were rendered 
pyrogen-free by heating to 180°C for 4 hours.
The lyophilized LAL (Whittaker, Walkersville, 
West Virginia) was reconstituted with SPFS accord­
ing to the manufacturer’s instructions. The reconsti­
tuted LAL was swirled gently but thoroughly without 
foaming for at least 30 seconds. The solution was 
dispensed into small sterile pyrogen-free tubes, de­
pending on the quantity necessary each day, and 
stored at ~20°C. Immediately before use, the frozen 
LAL tube was thawed at 37°C and kept on ice during 
the test.
Lyophilized endotoxin from Escherichia coli 
055:B5 (10 ng/vial) was used (Whittaker) as a stan­
dard. It was reconstituted by the addition of 5 ml SPFS 
followed by vigorous shaking for at least 5 minutes 
with a vortex mixer. This solution had a concentration 
of 2 ng/ml and was guaranteed by the manufacturer 
to be stable for 4 weeks at 4°C. Before use, the so­
lution was warmed to room temperature and mixed 
vigorously for 1 minute.
To determine the potency of the LAL and to verify 
the reproducibility of the test, duplicate twofold dilu­
tion series were made with a 100 pg/ml endotoxin 
solution. The 100 pg/ml endotoxin solution was made 
by diluting the stock solution. Two microliter samples 
of LAL were drawn up into a micropipette by means 
of capillarity (the same number as dilution steps), and
2 |al samples of each endotoxin solution were picked 
up in a micropipette. To mix endotoxin and LAL, the 
contents of each micropipette were blown out onto a 
slide (4 jal = 2 |Lil LAL + 2 [il endotoxin dilution). Of 
the mixture, 3 (il were reaspirated into the same mi­
cropipette. To circumvent penetration of air bubbles 
and evaporation of the mixture, the capillary was in­
cubated in a metal box ( 1 6 x 1 3 x 3  cm) in a horizon­
tally sloping position and in a humidified atmosphere. 
When all the endotoxin dilutions had been treated in
the same manner, the metal boxes were closed and 
placed for 60 minutes in an incubator at 37°C. For­
mation of the gel was detected by dipping the 
micropipettes one by one for 5 seconds vertically in 
a tube of the colored solution. If a firm gel was present 
the micropipette remained colorless, and the test was 
positive. A negative test was characterized by the ab­
sence of a gel, the micropipette becoming colored af­
ter immersion in the colored solution.
The oral washings were stored at -20°C. Before 
measuring, the test samples were warmed to room 
temperature. The samples were centrifuged (10,000 
gm, 10 minutes) in polypropylene tubes (Eppendorf, 
Hamburg, Germany) and the supematants were col­
lected. A 1:10 dilution series of up to 10~6 of the su­
pernatant in SPFS was made and tested with the LAL 
in the manner described for the LAL potency assay. 
The endotoxin concentration was estimated by mul­
tiplying the maximum dilution producing a positive 
test against the sensitivity of the LAL, which was 
verified daily with fresh endotoxin standard. Each 
first sample was centrifuged, diluted, and tested twice 
to determine the reproducibility of the method.
The lysate potency verification assay consisted of 
a minimum of four up to a maximum of eight dilu­
tion assays to determine that the geometric mean 
(GM) sensitivity value and the standard deviation 
(SD) of the endpoints were within acceptable ranges 
(6 pg to 250 pg/ml). A value within this range was 
considered equivalent to the value stated on the lysate 
vial label that was determined with the current U.S. 
Standard Endotoxin.
RESULTS
Fifteen healthy nonsmoking adults (eight women 
and 7 men) met the criteria for enrollment in the study. 
The median age was 29 years (range, 25 to 43 years). 
The mean plaque score of the healthy adult group was
1.2 ± 0.1. None of the subjects carried AGNB in the 
oropharynx. In addition, all volunteers were shown 
not to have yeasts and S. aureus in their mouth rinses. 
The mean concentration of endotoxin found in the 30 
oral mouth rinses was 20 ng/ml of mouth rinse (SD 
10) (Table I). The first series of 15 washes was tested 
twice. Identical endotoxin concentrations were found. 
There was no difference in the oral endotoxin levels 
between the two sets of samples. The LAL sensitiv­
ity value was found to be within the range (3 pg/ml 
versus 6 pg/ml) and considered to be equivalent to the 
value stated on the lysate vial label; this confirms that 
the lysate used in the study was as sensitive as claimed 
by the manufacturer. After the addition of endotoxin 
to the diluted samples, no inhibition was observed. 
The mean oral endotoxin concentration of 20 ng/ml
Table I. Oral endotoxin in two mouth rinses 
obtained from 15 healthy adults 1 week apart. Oral 
endotoxin concentrations are expressed in 
nanogram (ng) per ml of mouth wash.
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Volunteer
ng Endotoxin/ml 
Week 1 
(in duplicate)
ng Endotoxin/ml 
Week 2
1 3 3 3
l 15 15 15
3 15 15 30
4 30 30 30
5 15 15 15
6 30 30 30
7 15 15 15
8 30 30 30
9 30 30 30
10 3 3 3
11 30 30 30
12 30 30 30
13 30 30 30
14 30 30 15
15 30 30 30
Mean 21 21 19
SD 11 11 12
of oral washing was obtained with the aerobic E. coli 
endotoxin used as the classical standard. This is 
equivalent to 1 mg of anaerobic endotoxin per milli­
liter of undiluted saliva after correcting for the 
10-10“2 dilution factor of the mouth rinse itself and 
for the 10“3 x less sensitivity of anaerobic endotoxin 
in the LAL assay.
DISCUSSION
In healthy adults, 1 mg of anaerobic endotoxin per 
milliliter of undiluted saliva was found after correct­
ing for the dilution factor of the mouth rinse itself and 
for the less sensitivity of anaerobic endotoxin in the 
LAL assay with E . coli endotoxin used as the classi­
cal standard.
Six inclusion criteria were thought to guarantee the 
homogeneity of the healthy population studied. The 
healthy status of the 15 young nonsmoking adults 
(median age, 29 years) was confirmed clinically by 
the absence of any chronic or acute underlying 
disease that is associated with the oral AGNB carrier 
state. They had not taken any antimicrobial nor had 
they suffered any viral illness causing oral mucositis 
that promotes adherence of AGNB to oropharyngeal 
mucosae. Their healthy dentition was confirmed by 
the low semiquantitative plaque index of 1.2. Finally, 
the sensitive and reproducible mouth rinse method 
based on pre-enrichment in nutrient medium showed 
the 30 mouth rinses to be negative for AGNB, yeasts
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and S. aureus, reflecting the healthy status of the 
subjects enrolled in the baseline study.
The value of 1 mg of endotoxin per milliliter of 
undiluted saliva is highly likely to be generated by the 
indigenous anaerobic gram-negative bacilli such as 
Bacteroides sp carried in the oropharynx. This as­
sumption is based on the indirect proof that healthy 
persons do not carry AGNB in their oropharynx, and, 
hence that these absent abnormal bacteria were 
impossible to be responsible for this level of oral en­
dotoxin. Moreover, the culture methods used in the 
study were unable to show AGNB. Of course, the 
sensitivity of the microbiologic techniques is the de­
termining factor.
Mouth rinses have been shown to be superior com­
pared with throat swabs for three reasons: (1) gargling 
permits sampling of surfaces of the entire oropharyn­
geal cavity including tonsillar crypts and possibly 
otherwise inaccessible areas; (2) with the use of a de­
fined volume of saline solution and with the subject 
gargling for a specified period of time, there is a min­
imal variation of sampling; (3) the mean concentra­
tions of microorganisms received from gargle sam­
ples are higher than the mean concentrations of 
microorganisms obtained by the swab technique.17
To enhance the sensitivity of the saline gargle 
method, nine tenfold dilution steps in broth were 
made and immediately incubated at 37°C for 18 
hours; the traditional culturing methods only include 
three steps 10”1, 10“3, and 10“° in sterile phosphate- 
buffered saline solution from which 0.1 ml of each 
dilution is inoculated on blood agar followed by 24 
hours and 48 hours incubation. The sensitivitv of the 
method used in this study is further increased by the 
broth incubation immediately after collecting the 
sample (enrichment step) that permits detection of 
very low concentrations of microorganisms. This 
technique of pre-enrichment followed by the use of 
selective solid media has been described for the iso­
lation of small numbers of salmonellae and antibiot- 
ic-resistant bacteria from feces. The traditional 
technique without overnight culture is based on the 
concept that the dynamics of microbial growth in a 
mixed culture system are unpredictable. AGNB are 
reported to proliferate more rapidly than, for example, 
gram-positive cocci. The enrichment method for this 
study basically relies on that latter observation. De­
tection of oropharyngeal carriage of AGNB in low 
concentrations was the major aim of the use of the 
mouth rinse culture technique with overnight broth 
culture, because oral AGNB carriage is a sensitive 
marker of severity of underlying disease.5
The second technical issue is the sensitivity of the 
classical existing LAL assay using aerobic E> coli
endotoxin as control, for the detection of endotoxin of 
anaerobic gram-negative bacilli. Endotoxin or li- 
popolysaccharide (LPS) is released by gram-negative 
aerobic and anaerobic bacteria. LPS or endotoxin can 
be detected by means of the Limulus gelation assay. 
The assay is based on the principle that bacterial LPS 
specifically activate the clotting cascade in blood of 
the horseshoe crab Limulus polyphemus. This results 
in gelation of a lysate of the blood corpuscles (called 
amebocytes) of the horseshoe crab.19 The intrinsic 
endotoxicity of LPS of anaerobic gram-negative ba­
cilli such as Bacteroicles species is low compared with 
the endotoxin potency associated with AGNB such as 
E. coli, Bacteroides LPS causes gelation of the LAL 
assay at a concentration 1000 times higher than that 
for the aerobic endotoxin of E. coli,20’21 Bacteroides 
LPS differs from the classical E. coli LPS in that LPS 
of the anaerobic bacterium lacks two essential 2-ke- 
to-3 deoxyoctonate (KDO) and heptose.20 These in 
vitro findings are confirmed by the clinical observa­
tions that course and outcome of a septicemia caused 
by Bacteroides species is much more favorable than 
a blood infection caused by E. coli?2,23 There are no 
LAL tests commercially available with anaerobic 
LPS used as the standard. All manufactured LAL kits 
use E. coli LPS as control to detect AGNB-LPS. If 
one assumes that the assay used in our study under­
estimates gram-negative anaerobic LPS levels by 
1000 times, then the oral endotoxin level is probably 
20 jug/ml of mouth rinse. If the resting saliva levels 
are in the range of 0.1 to 1 ml/minute and 10 ml of the 
rinse is gargled, this represents a 1:10 to 1:100 dilu­
tion factor of the mouth rinse itself. The actual anaer­
obic LPS concentration in undiluted saliva may range 
from 0.1 to 1 mg/ml. Assuming that anaerobic LPS 
is 10'3 less sensitive, the absolute concentration of 
oral endotoxin does not represent a significant differ­
ence from the fecal endotoxin pool of 1 mg/gm of 
feces in healthy adults.18 What it does represent is 
perhaps the gram-negative anaerobe’s adaption to an 
environment that it wishes to colonize.
From a microbiologic point of view, the AGNB 
free carrier state apart from the indigenous £. coli in 
the gut in a concentration of 1.03~6 CFU/gm of feces 
reflects the healthy status of a person.14,24 From en­
dotoxin point of view, levels of 1 mg in both saliva 
and feces are found by our group. However, there is 
a crucial difference between the 1 mg of anaerobic 
endotoxin per milliliter of undiluted saliva and the 1 
mg of aerobic E. coli endotoxin per gram of feces. 
Anaerobic gram-negative endotoxin has a low endo­
toxicity, about 1000 times less, compared with the 
high endotoxic potency of AGNB endotoxin. In 
normal subjects the intravenous administration of a
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bolus of E. coli endotoxin (4 ng/Kg) caused a depres­
sion of the left ventricular function besides the 
cytokinemia.25 Our observations that about 1 mg of 
endotoxin is carried per milliliter and gram of saliva 
and feces, respectively, imply potent defense mech­
anisms to be in place at oropharyngeal and intestinal 
level to control absorption of endotoxin. Tradition­
ally, three lines of defense are being described. First, 
the intactness of anatomy and physiology of the 
oropharynx and gastrointestinal tract is paramount to 
keep endotoxin intraluminally. Second, in the case of 
absorption through the intact or damaged digestive 
tract mucosal lining, one of the functions of the mac­
rophages of both oropharynx- and gut-associated 
lymphatic tissue (GALT) is the neutralization of oral 
and gut endotoxin. Third, the blood composed of 
platelets, proteins, and leucocytes neutralizes the en­
dotoxin in the systemic circulation after spillover. 
Clearance of AGNB and endotoxin from the body is 
an important physiologic mechanism mainly based on 
their mechanical removal from throat and gut. The 
swallowing reflex, tongue movements, and salivary 
flow are all involved in the efficient cleansing of the 
oropharynx. AGNB are cleared from the oropharynx 
within 3 hours after challenge in human volunteers.26 
Salivary mucins are been described to neutralize en­
dotoxin.27 In analogy, gut motility and bile are piv­
otal in the clearance of gut AGNB or endotoxin.28,29 
The endotoxin barrier is not only physical but also 
immunologic. The uptake and subsequent detoxifica­
tion of endotoxin occurs in the mononuclear reticu- 
lo-endothelial system of the oropharynx-associated 
lymphoid tissue that contains the ring of Waldeyer 
including the adenoids, tonsils, and cervical lymph 
nodes and of the GALT including the liver primarily 
by Kupffer cells lining the sinusoidal vascular net­
work. Finally, apart from the bloodcells scavenging 
systemic endotoxin in case of endotoxin spillover 
(platelet consumption by endotoxin),11 there is recent 
evidence that supports the beneficial role of the low 
endotoxicity of anaerobic gram-negative flora in pro­
tecting the host from harmful inflammatory events 
such as SIRS.30,31 The major route of oral and gut 
endotoxin (or alimentary canal-derived cytokines) is 
thought to be lymphatic drainage into the right lym­
phatic and thoracic duct. These two lymph vessels re­
turn the lymph to the venous blood circulation and via 
the heart into the lungs. The alveolar macrophages in the 
lower airways are the target immune cells to be primed 
by endotoxin or cytokines.32,33 Anaerobic endotoxin 
has been shown to be unable directly to stimulate the 
macrophage in the release of tumor necrosis factor and 
precoagulant activity.30 Moreover, the specificity of 
molecular interaction of the macrophage with anaerobic
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Bacteroides LPS of low endotoxieity was found to block 
further stimulation by aerobic E. call endotoxin of high 
potency.31
Clinically, the presence of a chronic and acute un­
derlying condition such as diabetes, alcoholism, 
trauma, or surgery is associated with the detection of 
abnormal AGNB in oropharyngeal and gastrointesti­
nal secretions. The underlying mechanism is not 
clear. Some people believe that these diseases both 
chronic and acute are associated with macrophages 
releasing several inflammatory mediators34 and 
elastase.7 Elastase is also excreted in saliva, bile, and 
mucus and hence into oropharynx and gut and 
denudes the mucosal cells of their protective layer of 
fibronectin, exposing receptor sites for the AGNB. 
Increased adherence of the AGNB has been associ­
ated with the loss of fibronectin from the surface of 
the digestive tract mucosae because of the damaging 
inflammatory response. The indigenous both oropha­
ryngeal and intestinal anaerobic flora outnumber the 
aerobic bacteria by a factor of 102 to 104. Despite 
some favorable data the actual relevance of the 
anaerobic flora in the prevention of the abnormal 
AGNB carrier state associated with the underlying 
condition via bacterial interference35 is uncertain in 
human beings. Translocation of live AGNB does oc­
cur at both throat and gut level36,37 in spite of the 
presence of indigenous anaerobic gram-negative flora. 
Furthermore, AGNB carriage is likely to increase the 
LPS concentrations of high endotoxieity and, after 
absorption through the mucosal lining, to enhance the 
generalized inflammation state triggered by the un­
derlying condition. Excessive inflammation or SIRS 
still does occur despite the beneficial effect of low 
endotoxieity of the anaerobic gram-negative flora via 
blocking of sensitized macrophages against further 
stimulation by aerobic endotoxin. If the body’s larg­
est lymphoid organ of GALT38 fails to control 
microbial translocation and endotoxin absorption in 
critically ill patients, it is very unlikely that the 
oropharynx-associated lymphatic tissues that are mi­
nor compared with GALT are able to cope with oral 
AGNB and associated LPS of high endotoxieity. 
Topical polymyxin and tobramycin has been shown 
to be effective in eradicating the AGNB carrier state 
and in neutralizing endotoxin at both oropharyngeal 
and intestinal level.11’ L2*39*40
We thank Mrs. Lynda Jones for the skillful typing of the 
manuscript.
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